- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Serum Institute shuns reports of commercializing Covishield, says will sell only after successful trial
"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.
New Delhi: Serum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely false and conjectural.
"Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use", SII said in a statement.
"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.
"The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially", the statement said.
"Serum Institute of India, would like to clarify that the current claims surrounding Covishield's availability in the media are completely false and conjectural", it said.
The clarification came after reports that the vaccine would get commercialized in 73 days.
Read also: India Will Get COVID-19 Vaccine By 2020 End, Says Union Health Minister
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.